Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-α (PPARα) and PPARβ activity

Wasana K. Sumanasekera, Eric S. Tien, John W. Davis, Rex Turpey, Gary H. Perdew, John P.Vanden Heuvel

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

The nuclear receptor (NR) peroxisome proliferator-activated receptor-α (PPARα) mediates the effects of several hypolipidemic drugs, endogenous fatty acids, and peroxisome proliferators. Despite belonging to a class of NR not known to interact with cytosolic chaperone complexes, we have recently shown that PPARα interacts with heat shock protein 90 (Hsp90), although the biological consequence of this association was unknown. In the present study, PPARα directly associated with Hsp90 in vitro to a much greater extent than either PPARβ or PPARγ. This interaction is similar to other NR-Hsp90 complexes with association occurring between the middle of Hsp90 and the hinge (D) and ligand binding domain (EF) of PPARα. Using several different approaches to disrupt Hsp90 complexes within the cell, we demonstrate that Hsp90 is a repressor of both PPARα and PPARβ activity. Treatment with geldanamycin (GA) increased the activity of PPARα and in the presence of ligand in transient transfection assays. PPARα-response element (PPRE)-reporter assays in a stable cell line treated with GA resulted in enhanced expression of a known target gene, acyl-CoA oxidase. Similarly, overexpression of the tetratricopeptide repeat (TPR) of protein phosphatase 5 (PP5) increased PPARα or PPARβ activity in a PPRE-reporter assay and decreased the interaction between PPARα or PPARβ and Hsp90 in a mammalian two-hybrid assay. Finally, cotransfection with the C-terminal hsp-interacting protein (CHIP) construct, a TPR-containing ubiquitin ligase that interacts with hsp90, increased PPARα's and decreased PPARβ's ability to regulate PPRE-reporter activity upon ligand activation. All three methods to disrupt Hsp90 function (GA, PP5-TPR, CHIP) resulted in an alteration in PPARα or PPARβ activity to a much greater extent than PPARγ. While FKBP52 had no effect on PPARα activity, p23 greatly enhanced constitutive and Wy14 643 induced PPRE-reporter activity. Thus, we describe the chaperone complex as being a regulator of PPARα and PPARβ activity and have identified a novel, subtype-specific, inhibitory role for Hsp90.

Original languageEnglish (US)
Pages (from-to)10726-10735
Number of pages10
JournalBiochemistry
Volume42
Issue number36
DOIs
StatePublished - Sep 16 2003

Fingerprint

HSP90 Heat-Shock Proteins
Peroxisome Proliferator-Activated Receptors
Response Elements
Assays
Cytoplasmic and Nuclear Receptors
Ligands

All Science Journal Classification (ASJC) codes

  • Biochemistry

Cite this

Sumanasekera, Wasana K. ; Tien, Eric S. ; Davis, John W. ; Turpey, Rex ; Perdew, Gary H. ; Heuvel, John P.Vanden. / Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-α (PPARα) and PPARβ activity. In: Biochemistry. 2003 ; Vol. 42, No. 36. pp. 10726-10735.
@article{67274b7560ac4eadb1ae628795046fa0,
title = "Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-α (PPARα) and PPARβ activity",
abstract = "The nuclear receptor (NR) peroxisome proliferator-activated receptor-α (PPARα) mediates the effects of several hypolipidemic drugs, endogenous fatty acids, and peroxisome proliferators. Despite belonging to a class of NR not known to interact with cytosolic chaperone complexes, we have recently shown that PPARα interacts with heat shock protein 90 (Hsp90), although the biological consequence of this association was unknown. In the present study, PPARα directly associated with Hsp90 in vitro to a much greater extent than either PPARβ or PPARγ. This interaction is similar to other NR-Hsp90 complexes with association occurring between the middle of Hsp90 and the hinge (D) and ligand binding domain (EF) of PPARα. Using several different approaches to disrupt Hsp90 complexes within the cell, we demonstrate that Hsp90 is a repressor of both PPARα and PPARβ activity. Treatment with geldanamycin (GA) increased the activity of PPARα and in the presence of ligand in transient transfection assays. PPARα-response element (PPRE)-reporter assays in a stable cell line treated with GA resulted in enhanced expression of a known target gene, acyl-CoA oxidase. Similarly, overexpression of the tetratricopeptide repeat (TPR) of protein phosphatase 5 (PP5) increased PPARα or PPARβ activity in a PPRE-reporter assay and decreased the interaction between PPARα or PPARβ and Hsp90 in a mammalian two-hybrid assay. Finally, cotransfection with the C-terminal hsp-interacting protein (CHIP) construct, a TPR-containing ubiquitin ligase that interacts with hsp90, increased PPARα's and decreased PPARβ's ability to regulate PPRE-reporter activity upon ligand activation. All three methods to disrupt Hsp90 function (GA, PP5-TPR, CHIP) resulted in an alteration in PPARα or PPARβ activity to a much greater extent than PPARγ. While FKBP52 had no effect on PPARα activity, p23 greatly enhanced constitutive and Wy14 643 induced PPRE-reporter activity. Thus, we describe the chaperone complex as being a regulator of PPARα and PPARβ activity and have identified a novel, subtype-specific, inhibitory role for Hsp90.",
author = "Sumanasekera, {Wasana K.} and Tien, {Eric S.} and Davis, {John W.} and Rex Turpey and Perdew, {Gary H.} and Heuvel, {John P.Vanden}",
year = "2003",
month = "9",
day = "16",
doi = "10.1021/bi0347353",
language = "English (US)",
volume = "42",
pages = "10726--10735",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "36",

}

Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-α (PPARα) and PPARβ activity. / Sumanasekera, Wasana K.; Tien, Eric S.; Davis, John W.; Turpey, Rex; Perdew, Gary H.; Heuvel, John P.Vanden.

In: Biochemistry, Vol. 42, No. 36, 16.09.2003, p. 10726-10735.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-α (PPARα) and PPARβ activity

AU - Sumanasekera, Wasana K.

AU - Tien, Eric S.

AU - Davis, John W.

AU - Turpey, Rex

AU - Perdew, Gary H.

AU - Heuvel, John P.Vanden

PY - 2003/9/16

Y1 - 2003/9/16

N2 - The nuclear receptor (NR) peroxisome proliferator-activated receptor-α (PPARα) mediates the effects of several hypolipidemic drugs, endogenous fatty acids, and peroxisome proliferators. Despite belonging to a class of NR not known to interact with cytosolic chaperone complexes, we have recently shown that PPARα interacts with heat shock protein 90 (Hsp90), although the biological consequence of this association was unknown. In the present study, PPARα directly associated with Hsp90 in vitro to a much greater extent than either PPARβ or PPARγ. This interaction is similar to other NR-Hsp90 complexes with association occurring between the middle of Hsp90 and the hinge (D) and ligand binding domain (EF) of PPARα. Using several different approaches to disrupt Hsp90 complexes within the cell, we demonstrate that Hsp90 is a repressor of both PPARα and PPARβ activity. Treatment with geldanamycin (GA) increased the activity of PPARα and in the presence of ligand in transient transfection assays. PPARα-response element (PPRE)-reporter assays in a stable cell line treated with GA resulted in enhanced expression of a known target gene, acyl-CoA oxidase. Similarly, overexpression of the tetratricopeptide repeat (TPR) of protein phosphatase 5 (PP5) increased PPARα or PPARβ activity in a PPRE-reporter assay and decreased the interaction between PPARα or PPARβ and Hsp90 in a mammalian two-hybrid assay. Finally, cotransfection with the C-terminal hsp-interacting protein (CHIP) construct, a TPR-containing ubiquitin ligase that interacts with hsp90, increased PPARα's and decreased PPARβ's ability to regulate PPRE-reporter activity upon ligand activation. All three methods to disrupt Hsp90 function (GA, PP5-TPR, CHIP) resulted in an alteration in PPARα or PPARβ activity to a much greater extent than PPARγ. While FKBP52 had no effect on PPARα activity, p23 greatly enhanced constitutive and Wy14 643 induced PPRE-reporter activity. Thus, we describe the chaperone complex as being a regulator of PPARα and PPARβ activity and have identified a novel, subtype-specific, inhibitory role for Hsp90.

AB - The nuclear receptor (NR) peroxisome proliferator-activated receptor-α (PPARα) mediates the effects of several hypolipidemic drugs, endogenous fatty acids, and peroxisome proliferators. Despite belonging to a class of NR not known to interact with cytosolic chaperone complexes, we have recently shown that PPARα interacts with heat shock protein 90 (Hsp90), although the biological consequence of this association was unknown. In the present study, PPARα directly associated with Hsp90 in vitro to a much greater extent than either PPARβ or PPARγ. This interaction is similar to other NR-Hsp90 complexes with association occurring between the middle of Hsp90 and the hinge (D) and ligand binding domain (EF) of PPARα. Using several different approaches to disrupt Hsp90 complexes within the cell, we demonstrate that Hsp90 is a repressor of both PPARα and PPARβ activity. Treatment with geldanamycin (GA) increased the activity of PPARα and in the presence of ligand in transient transfection assays. PPARα-response element (PPRE)-reporter assays in a stable cell line treated with GA resulted in enhanced expression of a known target gene, acyl-CoA oxidase. Similarly, overexpression of the tetratricopeptide repeat (TPR) of protein phosphatase 5 (PP5) increased PPARα or PPARβ activity in a PPRE-reporter assay and decreased the interaction between PPARα or PPARβ and Hsp90 in a mammalian two-hybrid assay. Finally, cotransfection with the C-terminal hsp-interacting protein (CHIP) construct, a TPR-containing ubiquitin ligase that interacts with hsp90, increased PPARα's and decreased PPARβ's ability to regulate PPRE-reporter activity upon ligand activation. All three methods to disrupt Hsp90 function (GA, PP5-TPR, CHIP) resulted in an alteration in PPARα or PPARβ activity to a much greater extent than PPARγ. While FKBP52 had no effect on PPARα activity, p23 greatly enhanced constitutive and Wy14 643 induced PPRE-reporter activity. Thus, we describe the chaperone complex as being a regulator of PPARα and PPARβ activity and have identified a novel, subtype-specific, inhibitory role for Hsp90.

UR - http://www.scopus.com/inward/record.url?scp=0042318859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042318859&partnerID=8YFLogxK

U2 - 10.1021/bi0347353

DO - 10.1021/bi0347353

M3 - Article

C2 - 12962497

AN - SCOPUS:0042318859

VL - 42

SP - 10726

EP - 10735

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 36

ER -